Can I drink alcohol while taking nintedanib ethanesulfonate soft capsules?

Nintedanib ethanesulfonate (Nintedanib) soft capsule is a targeted drug used to treat idiopathic pulmonary fibrosis and certain types of non-small cell lung cancer. When many patients receive this treatment, they will have questions about whether drinking alcohol will affect the efficacy of the drug or increase side effects. Although there are currently no clear studies showing a direct interaction between nintedanib ethanesulfonate and alcohol, drinking alcohol may have a certain impact on patients' health from many aspects.

One of the main side effects of nintedanib ethanesulfonate is gastrointestinal reactions, such as nausea, vomiting, diarrhea, etc. Alcohol itself is a stimulant and may aggravate these symptoms, causing patients to feel more uncomfortable while taking the medication. In addition, drinking alcohol may affect the absorption and metabolism of drugs, thereby affecting their efficacy. If patients drink alcohol while taking nintedanib, it may affect the concentration and effect of the drug in the body, thereby affecting the therapeutic effect.

Nintedanib ethanesulfonate will also have a certain impact on liver function. The liver is the main organ for drug metabolism, and drinking alcohol may further increase the burden on the liver, especially for patients with existing liver damage. This effect may be more obvious. Therefore, for patients with normal liver function, if they decide to drink alcohol occasionally, they should do so in moderation and under the guidance of a doctor. If the patient has a history of abnormal liver function, he should avoid drinking alcohol to avoid aggravating the condition.

During the use of nintedanib ethanesulfonate, patients need to undergo regular health monitoring, including liver function indicators and routine blood tests. Drinking alcohol may interfere with these test results, preventing doctors from accurately assessing the patient's health status, thereby affecting subsequent treatment decisions. Therefore, in order to ensure the effectiveness and safety of treatment, it is best for patients to limit alcohol consumption while taking nintedanib ethanesulfonate, especially in the early stages of treatment.

Reference materials:https://www.drugs.com/food-interactions/nintedanib.html